INBISTRA

Strategic Consulting for Drug Discovery & Early-Stage Biopharma INBISTRA is a boutique management consulting firm specialized in empowering preclinical research and early-stage bioscience companies. We transform scientific breakthroughs into real-world therapeutic progress—faster, smarter, and with a clear path to value creation through personalized, data-driven strategies. Our core mission is to guide entrepreneurs, biotechs, SMEs, and investors in optimizing early-stage portfolios, reduce risks, and accelerate the journey from discovery to the clinic. What sets us apart? A PhD-led senior team with decades of hands-on experience in the discovery and translation of new drugs into the clinic across global pharma, biotech, and academia, enhanced by proprietary AI-powered analytics. We combine scientific insight and business acumen to guide strategic decisions on: • Asset scouting and portfolio evaluation • Go/no-go inflection points • Business development and partnerships • Interim executive leadership and project oversight We’re not generalists. We focus where others don’t: the critical preclinical window, where even the strongest science needs the right strategic focus and market alignment to reach its full potential. At INBISTRA, we bring clarity to complexity using cutting-edge tools, insights, and goal-driven strategic plans to turn early science into viable therapies. As your dedicated partners, we ensure every client receives focused, senior-level attention. Let’s rethink what preclinical success looks like.